Top Markets
#1 ADO Protocol ADO Protocol +329.39%
#2 GoPlus Security GoPlus Security +52.29%
#3 Nockchain Nockchain +48.47%
#4 The Black Bull The Black Bull +39.67%
#5 Starpower Starpower +34.78%
#6 Tutorial Tutorial +32.63%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.47%
#8 Fake World Assets Fake World Assets +27.22%
#9 GAIB AID GAIB AID +24.67%
#10 Verus Coin Verus Coin +20.20%
Coin of the day
ADO Protocol ADO Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Eusol Biotech Co.,Ltd. Eusol Biotech Co.,Ltd.

Eusol Biotech Co.,Ltd.

6652
Clasificación en acciones #33025
Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the... Eusol Biotech Co.,Ltd. is a biopharmaceutical firm primarily dedicated to the discovery and advancement of innovative biotechnological treatments for various sleep-related conditions. Its current development portfolio showcases two key candidates: ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) designed to restore and repair neuronal function; and SM-1, a singular capsule formulation that combines three commercially available sedative medications. The company commenced operations in 1994 and maintains its principal offices in Taipei, Taiwan.
Precio por acción
$0.06232609
Última sincronización: 2026-04-09
Capitalización bursátil
$8.54M
Cambio (1 día)
-12.89%
Cambio (1 año)
-68.75%
País
TW
Comercio Eusol Biotech Co.,Ltd. (6652)

Categoría

Healthcare
Ganancias de Eusol Biotech Co.,Ltd. (6652)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Eusol Biotech Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Eusol Biotech Co.,Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE